Stephen P. Squinto - May 20, 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Director, 10%+ Owner
Signature
/s/ Francis I. Perier, Jr as Attorney-in-Fact
Stock symbol
SWTX
Transactions as of
May 20, 2021
Transactions value $
$0
Form type
4
Date filed
5/21/2021, 04:31 PM
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Award $0 +1.11K +0.88% $0.00 127K May 20, 2021 Direct F1
holding SWTX Common Stock 6.19M May 20, 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Award $0 +7K $0.00 7K May 20, 2021 Common Stock 7K $75.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock awards. The restricted stock awards shall vest in full on the earlier of (1) May 20, 2022 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.
F2 Shares held by OrbiMed Private Investments VI, LP ("OrbiMed VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OrbiMed VI. OrbiMed Advisors, LLC ("Advisors") is the managing member of GP VI. By virtue of such relationship, GP VI and Advisors may be deemed to have voting and investment power with respect to the shares held by OrbiMed VI and as a result may be deemed to have beneficial ownership of such shares. The reporting person is an Executive Partner at Advisors. This report shall not be deemed an admission that the reporting person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
F3 The options shall vest in full on the earlier of (1) May 20, 2022 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer on the vesting date.